Stereotactic radiotherapy in recurrent gynecological cancer: A case series

Oncology Reports

Volumn 22, Issue 2, 2009, Pages 415-419

  Deodato, Francesco ^a   Macchia, Gabriella ^a   Grimaldi, Luca ^a   Ferrandina, Gabriella ^a,b   Lorusso, Domenica ^b   Salutari, Vanda ^a   Cilla, Savino ^a   Valentini, Vincenzo ^b   Cellini, Numa ^b   Piermattei, Angelo ^a   Scambia, Giovanni ^b   Morganti, Alessio Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Extracranial stereotactic radiotherapy; Gynaecological tumor; Radiotherapy; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE STUDY; CLINICAL ARTICLE; DOSIMETRY; FEMALE; GYNECOLOGIC CANCER; HUMAN; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECURRENT CANCER; RETREATMENT; STEREOTACTIC TREATMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY;

EID: 68349118151     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000453     Document Type: Article

References (25)

1. Van Wijk FH, Huikeshoven FJ, Abdulkadir L, et al: Recurrent endometrial cancer: a retrospective study. Eur J Obstet Gynecol Reprod Biol 130: 114-120, 2007.
2. Elst P, Ahankour F and Tjalma W: Management of recurrent cervical cancer. Review of the literature and case report. Eur J Gynaecol Oncol 28: 435-441, 2007.
3. Potters L, Steinberg M, Rose C, et al: American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guidelines for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 60: 1026-1032, 2004.
4. Wulf J, Haedinger U, Oppitz U, et al: Stereotactic boost irradiation for targets in abdomen and pelvis. Radiother Oncol 70: 31-36, 2004.
5. Wulf J, Guckemberger M, Haedinger U et al: Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45: 838-847, 2006.
6. Madsen BL, Hsi RA, Pham HT, et al: Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67: 1099-1105, 2007.
7. Nagata Y, Matsuo Y, Takayama K, et al: Current status of stereotactic radiotherapy for lung cancer. Int J Clin Oncol 12: 3-7, 2007.
8. Werfall PJ, Blomgren H, Lax I, et al: Extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Radioth Oncol 77: 88-95, 2005.
9. Molla M, Escude L, Nouet P, et al: Fractionated stereotactic radiotherapy boost for ginecologic tumors: an alternative to brachytherapy? Int J Radiat Oncol Biol Phys 62: 118-124, 2005.
10. Bogart JA: Stereotactic body radiotherapy for poor-risk lung cancer: 'more cyber, less knife?' Cancer J 13: 75-77, 2007.
11. Brown WT, Wu X, Amendola B, et al: Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation - CyberKnife. Cancer J 13: 87-94, 2007.
12. Kavanagh BD, McGarry RC and Timmerman R: Extracranial radiosurgery stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 16: 77-84, 2006.
13. Timmerman RD and Story M: Stereotactic body radiation therapy: a treatment in need of basic biological research. Cancer J 12: 19-20, 2006.
14. Salazar OM, Sandhu TS, Lattin PB, et al: Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. Int J Radiat Oncol Biol Phys 72: 707-715, 2008.
15. Chua DT, Wei WI, Sham JS, et al: Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 69: 469-474, 2007.
16. Chang EL, Shiu AS, Mendel E, et al: Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7: 151-160, 2007.
17. Sailer SL, Rosenman JG, Symon JR, et al: The tetrad and hexad: maximum beam separation as a starting point for non-coplanar 3D treatment planning: prostate cancer as a test case. Int J Radiat Oncol Biol Phys 30: 439-446, 1994.
18. Papiez L, Timmerman R, DesRosiers C and Randall M: Extracranial stereotactic radioablation: physical principles. Acta Oncol 42: 882-894, 2003.
19. Perez CA and Brady LW: Overview. In: Principles and Practices of Radiation Oncology. 2nd edition. Perez CA and Brady LW (eds). Lippincott Company, Philadelphia, PA, pp1-63, 1992.
20. Miller AB, Hoogstraten B, Staquet M and Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
21. Sutherland HJ, Walker P and Till JE: The development of a method for determining oncology patients' emotional distress using linear analogue scales. Cancer Nurs 11: 303-308, 1988.
22. Salazar OM, Sandhu T, Da Motta NW, et al: Fractionated half-body irradiation HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 50: 765-775, 2001.
23. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Statist Assoc 53: 457-481, 1985.
24. Pectasides D, Kamposioras K, Papaxoinis G and Pectasides E: Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 34: 603-613, 2008.
25. Rubin P, Brasacchio R and Katz A: Solitary metastases: illusion versus reality. Semin Radiat Oncol 16: 120-130, 2006.